Close Menu

NEW YORK (GenomeWeb) – Invitae announced today that it has completed its acquisition of CombiMatrix.

With the closing of the deal, Invitae issued approximately $21.2 million in shares of its own common stock, about 2.7 million shares, to former CombiMatrix shareholders. Combined with the approximately 1.7 million shares of Invitae common stock underlying CombiMatrix Series F warrants assumed in the acquisition, the transaction has a total enterprise value of approximately $34.9 million, Invitae said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.